Plus Therapeutics Inc [NASDAQ: PSTV] price surged by 1.80 percent to reach at $0.01.
The one-year PSTV stock forecast points to a potential upside of 89.47. The average equity rating for PSTV stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Plus Therapeutics Inc [PSTV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PSTV shares is $6.17 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PSTV stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
D. Boral Capital have made an estimate for Plus Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 17, 2025. While these analysts kept the previous recommendation, Ladenburg Thalmann raised their target price to Buy. The new note on the price target was released on January 25, 2021, representing the official price target for Plus Therapeutics Inc stock. Previously, the target price had yet another raise to $6, while Maxim Group analysts kept a Buy rating on PSTV stock.
The Average True Range (ATR) for Plus Therapeutics Inc is set at 0.22, with the Price to Sales ratio for PSTV stock in the period of the last 12 months amounting to 1.90.
PSTV Stock Performance Analysis:
Plus Therapeutics Inc [PSTV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -18.64. With this latest performance, PSTV shares gained by 11.09% in over the last four-week period, additionally sinking by -52.48% over the last 6 months – not to mention a drop of -65.00% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PSTV stock in for the last two-week period is set at 41.22, with the RSI for the last a single of trading hit 36.35, and the three-weeks RSI is set at 43.33 for Plus Therapeutics Inc [PSTV]. The present Moving Average for the last 50 days of trading for this stock 1.0106, while it was recorded at 0.7335 for the last single week of trading, and 1.3017 for the last 200 days.
Insight into Plus Therapeutics Inc Fundamentals:
Plus Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.31 and a Current Ratio set at 0.31.
PSTV Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PSTV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Plus Therapeutics Inc go to 49.80%.
Plus Therapeutics Inc [PSTV] Institutonal Ownership Details
There are presently around $11.43%, or 12.17%% of PSTV stock, in the hands of institutional investors.
